Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000899243-02-000881
Filing Date
2002-03-29
Accepted
2002-03-29 00:00:00
Documents
7
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405 d10k405.txt 10-K405 292421
3 COLLABORATIVE RESEARCH AND DEVELOPMENT AGREEMENT dex1046.txt EX-10.46 192618
4 DISCOVERWORKS DRUG DISCOVERY COLLABORATION AGREEMENT dex1047.txt EX-10.47 173604
5 LICENSE AGREEMENT dex1048.txt EX-10.48 150189
6 STATEMENT OR COMPUTATION OF PER SHARE INCOME dex111.txt EX-11.1 5466
7 CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS dex231.txt EX-23.1 520
8 INDEPENDENT AUDITORS' CONSENT dex232.txt EX-23.2 615
  Complete submission text file 0000899243-02-000881.txt   817747
Mailing Address 665 STOCKTON DRIVE SUITE 104 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 104 EXTON PA 19341 6104588959
3 DIMENSIONAL PHARMACEUTICALS INC (Filer) CIK: 0000914201 (see all company filings)

EIN.: 232716487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 001-16019 | Film No.: 02594669
SIC: 2834 Pharmaceutical Preparations